Axxcess Wealth Management LLC Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Axxcess Wealth Management LLC trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 35.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,876 shares of the medical equipment provider’s stock after selling 1,011 shares during the period. Axxcess Wealth Management LLC’s holdings in Intuitive Surgical were worth $377,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in the stock. RB Capital Management LLC raised its holdings in shares of Intuitive Surgical by 4.4% in the 1st quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider’s stock valued at $523,000 after purchasing an additional 73 shares in the last quarter. IFM Investors Pty Ltd raised its holdings in shares of Intuitive Surgical by 25.6% in the 1st quarter. IFM Investors Pty Ltd now owns 60,188 shares of the medical equipment provider’s stock valued at $18,158,000 after purchasing an additional 12,269 shares in the last quarter. DAVENPORT & Co LLC raised its holdings in shares of Intuitive Surgical by 10.2% in the 1st quarter. DAVENPORT & Co LLC now owns 1,071 shares of the medical equipment provider’s stock valued at $323,000 after purchasing an additional 99 shares in the last quarter. Waldron Private Wealth LLC raised its holdings in shares of Intuitive Surgical by 11.4% in the 1st quarter. Waldron Private Wealth LLC now owns 1,724 shares of the medical equipment provider’s stock valued at $520,000 after purchasing an additional 176 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its holdings in shares of Intuitive Surgical by 0.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider’s stock valued at $133,012,000 after purchasing an additional 3,982 shares in the last quarter. 82.44% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Gary S. Guthart sold 44,203 shares of the company’s stock in a transaction on Friday, October 21st. The shares were sold at an average price of $210.84, for a total value of $9,319,760.52. Following the sale, the chief executive officer now directly owns 23,297 shares of the company’s stock, valued at approximately $4,911,939.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $210.76, for a total transaction of $1,343,595.00. Following the sale, the director now directly owns 11,224 shares of the company’s stock, valued at $2,365,570.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary S. Guthart sold 44,203 shares of the stock in a transaction on Friday, October 21st. The stock was sold at an average price of $210.84, for a total transaction of $9,319,760.52. Following the sale, the chief executive officer now directly owns 23,297 shares in the company, valued at $4,911,939.48. The disclosure for this sale can be found here. Insiders have sold 72,953 shares of company stock valued at $15,867,996 in the last ninety days. Insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent research reports. Morgan Stanley boosted their price target on shares of Intuitive Surgical from $215.00 to $235.00 and gave the company an “equal weight” rating in a report on Wednesday, October 19th. Jefferies Financial Group initiated coverage on shares of Intuitive Surgical in a research note on Wednesday, October 12th. They set a “hold” rating and a $210.00 price objective for the company. Truist Financial boosted their price objective on shares of Intuitive Surgical from $260.00 to $300.00 in a research note on Monday, November 14th. Barclays initiated coverage on shares of Intuitive Surgical in a research note on Monday, October 17th. They set an “overweight” rating and a $235.00 price objective for the company. Finally, Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $250.00 to $260.00 and gave the stock a “buy” rating in a research note on Friday, September 9th. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $261.05.

Intuitive Surgical Price Performance

ISRG stock opened at $264.45 on Thursday. The firm’s fifty day simple moving average is $219.05 and its 200-day simple moving average is $216.96. The company has a market capitalization of $93.45 billion, a P/E ratio of 69.78, a price-to-earnings-growth ratio of 5.79 and a beta of 1.38. Intuitive Surgical, Inc. has a 12 month low of $180.07 and a 12 month high of $369.21.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last released its quarterly earnings data on Tuesday, October 18th. The medical equipment provider reported $1.19 EPS for the quarter, beating the consensus estimate of $1.12 by $0.07. The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.52 billion. Intuitive Surgical had a net margin of 22.52% and a return on equity of 11.54%. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.04 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 3.79 earnings per share for the current year.

Intuitive Surgical Company Profile

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.